Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ZZ Biotech LLC is a clinical stage company developing innovative biologic treatments for ischemic stroke, amyotrophic lateral sclerosis (ALS), other neurological diseases, and wound healing applications including the treatment of diabetic foot ulcers. ZZ Biotech was formed to focus on the development of 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Instit...
ZZ Biotech LLC is a clinical stage company developing innovative biologic treatments for ischemic stroke, amyotrophic lateral sclerosis (ALS), other neurological diseases, and wound healing applications including the treatment of diabetic foot ulcers. ZZ Biotech was formed to focus on the development of 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. Eli Lilly received FDA approval in 2001 for wild-type activated protein C (wt-APC - Xigris) for the treatment of severe sepsis.

List your booth number for exhibitions, ask us